The above three markers can be obtained from serum (22, 36), and it has not been studied whether serum levels of neurotensin, pannexin-1 and sestrin-2 are related to sleep quality and cognitive function in patients with CID. The gene discussed is SESN2; the disease is combined immunodeficiency.